MapLight Therapeutics (MPLT) Other Non Operating Income (2024 - 2025)
MapLight Therapeutics (MPLT) reported Other Non Operating Income of $1.4 million for Q4 2025, up 109.4% on a YoY basis from $649000.0 in Q4 2024, and up 155.93% sequentially from $531000.0 in Q3 2025.
MapLight Therapeutics (MPLT) Other Non Operating Income (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Other Non Operating Income data on file, last reported at $1.4 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income rose 109.4% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (changed N/A YoY), and the FY2025 full-year result was $2.4 million, up 30.57% from the prior year.
- Other Non Operating Income advanced to $1.4 million in Q4 2025, from $531000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q4 2025 to a low of $531000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | MapLight Therapeutics | 314.07 Mn | 314.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 531,000.00 |
| Dec 31, 2024 | 649,000.00 |
| Sep 30, 2024 | 797,000.00 |